References
1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet . Feb 15
2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
2. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology
of 2019 novel coronavirus: implications for virus origins and receptor
binding. Lancet . Feb 22 2020;395(10224):565-574.
doi:10.1016/S0140-6736(20)30251-8
3. Hanaei S, Rezaei N. COVID-19: Developing from an Outbreak to A
Pandemic. Arch Med Res . May 13
2020;doi:10.1016/j.arcmed.2020.04.021
4. Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology . Nov
2003;8 Suppl:S9-14. doi:10.1046/j.1440-1843.2003.00518.x
5. Morra ME, Van Thanh L, Kamel MG, et al. Clinical outcomes of current
medical approaches for Middle East respiratory syndrome: A systematic
review and meta-analysis. Rev Med Virol . May 2018;28(3):e1977.
doi:10.1002/rmv.1977
6. Jabbari P, Jabbari F, Ebrahimi S, Rezaei N. COVID-19: A Chimera of
Two Pandemics. Disaster Med Public Health Prep . Jun 25 2020:1-3.
doi:10.1017/dmp.2020.223
7. Wang K, Chen W, Zhou Y-S, et al. SARS-CoV-2 invades host cells via a
novel route: CD147-spike protein. bioRxiv . 2020;
8. Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal
COVID-19 cases: A systematic literature review and meta-analysis.J Infect . Apr 23 2020;doi:10.1016/j.jinf.2020.04.021
9. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet . Mar 28
2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3
10. Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the
progression and prognosis of COVID-19. Diabetes Metab Res Rev .
Mar 31 2020:e3319. doi:10.1002/dmrr.3319
11. Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes:
Knowledge in progress. Diabetes Res Clin Pract . Apr
2020;162:108142. doi:10.1016/j.diabres.2020.108142
12. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19:
Prevalence, pathophysiology, prognosis and practical considerations.Diabetes Metab Syndr . Apr 9 2020;14(4):303-310.
doi:10.1016/j.dsx.2020.04.004
13. Huang YT, Lee YC, Hsiao CJ. Hospitalization for
ambulatory-care-sensitive conditions in Taiwan following the SARS
outbreak: a population-based interrupted time series study. J
Formos Med Assoc . May 2009;108(5):386-94.
doi:10.1016/S0929-6646(09)60082-6
14. Cabezudo-Garcia P, Ciano-Petersen NL, Mena-Vazquez N, Pons-Pons G,
Castro-Sanchez MV, Serrano-Castro PJ. Incidence and case fatality rate
of COVID-19 in patients with active epilepsy. Neurology . Jun 17
2020;doi:10.1212/WNL.0000000000010033
15. Kuroda N. Epilepsy and COVID-19: Associations and important
considerations. Epilepsy Behav . Jul 2020;108:107122.
doi:10.1016/j.yebeh.2020.107122
16. Yasri S, Wiwanikit V. COVID-19 and Epilepsy. Ann Indian Acad
Neurol . Apr 2020;23(Suppl 1):S43. doi:10.4103/aian.AIAN_254_20
17. Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19:
Friend or foe? Life Sci . Jun 2 2020;256:117900.
doi:10.1016/j.lfs.2020.117900
18. Lotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from
pathogenicity of the virus to clinical consequences. J Med Virol .
Jun 3 2020;doi:10.1002/jmv.26123
19. Singh JA, Cleveland JD. Serious Infections in People with Gout in
the United States: A National Study of Incidence, Time-trends and
Outcomes. Arthritis Care Res (Hoboken) . Apr 5
2020;doi:10.1002/acr.24201
20. Bono MJ, Reygaert WC. Urinary Tract Infection. StatPearls .
2020.
21. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with
in-hospital death of patients with COVID-19. Kidney Int . May
2020;97(5):829-838. doi:10.1016/j.kint.2020.03.005
22. Rudrapal M, Khairnar SJ, Borse LB, Jadhav AG. Coronavirus
Disease-2019 (COVID-19): An Updated Review. Drug Res (Stuttg) .
Aug 3 2020;doi:10.1055/a-1217-2397
23. Sun YJ, Feng YJ, Chen J, Li B, Luo ZC, Wang PX. Clinical features of
fatalities in patients with COVID-19. Disaster Med Public Health
Prep . Jul 15 2020:1-10. doi:10.1017/dmp.2020.235